Mergers and Acquisitions — The 5 Biggest Deals of Q2

These companies led the mergers and acquisitions charge in Q2

    View All  
Mergers and Acquisitions — The 5 Biggest Deals of Q2

Mergers and acquisitions continued to run at a red-hot pace in the second quarter with no sign of a let up. Heck, we’re not even halfway through 2014, and already the total value of global deal activity is at $1.75 trillion, according to Dealogic — a buyout pace not seen since the pre-crisis days of 2007.

handshake Mergers and Acquisitions    The 5 Biggest Deals of Q2The mergers and acquisition frenzy was so intense in the second quarter that some of the most exciting deals were the ones that didn’t get done — like Pfizer’s (PFE) failed $119 billion bid for AstraZeneca (AZN), or AbbVie’s (ABBV) pursuit of Shire (SHPG) for $46 billion.

Just think of all the handwringing and hype devoted to Apple (AAPL) and its buyout of Beats. The deal dominated the headlines, and yet — at $3 billion — was so comparatively small it didn’t come close to cracking the list of biggest mergers and acquisitions of the second quarter.

Indeed, Apple would have had to shell out nearly five times as many billions to make the list of top mergers and acquisitions for the April-June period — and that’s counting only deals in which at least one company had a listing on a major U.S. exchange.

Just have a look at the top five mergers and acquisitions in the second quarter:


Article printed from InvestorPlace Media, http://investorplace.com/2014/06/mergers-and-acquisitions-buyouts/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.